Valion Bio market cap VBIO
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Nov 2, 2026
- $471.2K
- Highest close in our data
- $430.2M
- Aug 2022
Valion Bio is worth $471.2K at the close on Nov 2, 2026, at $0.53 a share.
That is down 80% over the last year.
Its highest close in our data was $430.2M in Aug 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $471.2K | $471.2K | $3.8M | −83% |
| 2025 | $2.8M | $1.7M | $80.2M | −93% |
| 2024 | $41.8M | $12.6M | $53.8M | −7% |
| 2023 | $44.9M | $18.9M | $149M | −57% |
| 2022 | $105.3M | $102M | $430.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Valion Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| VBIOValion Bio | $471.2K |
| LABTLakewood-Amedex Biotherapeutics | $438.4K |
| SBFMSunshine Biopharma | $533.1K |
| DCOYDecoy Therapeutics | $678.1K |
| JAGXJaguar Health | $304.6K |
| NXTSNexentis Technologies | $772.3K |
| LNAILunai Bioworks | $830.7K |
| ARTLArtelo Biosciences | $1.1M |
| GOVXGeoVax Labs | $1.2M |
| MTNBMatinas BioPharma | $1.3M |
| KAPAKairos Pharma, LTD. | $1.6M |
| Peer median | $801.5K |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Valion Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.